Ogoc, Antonio M.

HRN: 28-51-66  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/03/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/03/2026
02/09/2026
IV
2.25g
Q8
Cellulitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines